The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia.
Christielly Rodrigues-SilvaAgostinho Tavares SemedoHiasmin Franciely da Silva NeriRosana Pereira VianelloCarlos Galaviz-HernándezMartha Sosa-MacíasRodrigo Bernini de BritoPaulo César GhediniPublished in: Neuropsychiatric disease and treatment (2020)
These results show that CYP2C19*2 and CYP2C19*17 polymorphisms influence CLZ responses during schizophrenia treatment.
Keyphrases